Law firms Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’ Sophie Chan · 9 February 2024 · 4 min read Profile Life Sciences Yearbook 2024 Baker McKenzie’s Jaspreet Takhar on the future of digital health solutionsWhat made you decide to specialise in life sciences law? Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact jasmine.glass@legalbusiness.co.uk Related ContentMore in this categoryM&A perspectives: Lorenzo CorteLaw firmsIman Tribak26 Jun 2024M&A perspectives: Melissa FogartyLaw firmsIman Tribak26 Jun 2024M&A perspectives: Jennifer BethlehemLaw firmsIman Tribak26 Jun 2024‘You’d be a brave innovator to ignore the UK’ – why patent work is booming in the post-Brexit UK life sciences marketLaw firmsMarie Johansen Nordland9 Feb 2024Taking back control – the post-pandemic landscape for life sciences regulationLaw firmsSophie Chan9 Feb 2024Life Sciences perspectives: Grant CastleLaw firmsSophie Chan9 Feb 2024Transatlantic firms outstrip peers on five-year PEP growth, LB100 data revealsLaw firmsAlex Ryan20 Dec 2024A good time to be mid-tier: private equity interest on the rise as mid-market thrivesLaw firmsTom Cox18 Dec 2024The LB100 ranked by PEP: firms push partner profits to new heights as associate pay debate rumbles onLaw firmsAlex Ryan18 Dec 2024